Elotuzumab

Category: Cancer

Elotuzumab Overview

Elotuzumab (brand name Empliciti, (Bristol-Myers Squibb and AbbVie), previously known as HuLuc63) is a humanized monoclonal antibody used in relapsed multiple myeloma.[1] The package insert denotes its mechanism as a SLAMF7-directed (also known as CD 319) immunostimulatory antibody.[2] Contents 1 Approvals and indications 1.1 Multiple myeloma 2 References 3 External links Approvals and indications Multiple myeloma In May 2014, it was granted "Break...

Read more Elotuzumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Elotuzumab

Recent Elotuzumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Elotuzumab or a similar ingredient: (1 result)

• EMPLICITI Elotuzumab